These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24996140)

  • 1. Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands.
    Łażewska D; Więcek M; Ner J; Kamińska K; Kottke T; Schwed JS; Zygmunt M; Karcz T; Olejarz A; Kuder K; Latacz G; Grosicki M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2014 Aug; 83():534-46. PubMed ID: 24996140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
    Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl-1,3,5-triazine ligands of histamine H
    Mogilski S; Kubacka M; Łażewska D; Więcek M; Głuch-Lutwin M; Tyszka-Czochara M; Bukowska-Strakova K; Filipek B; Kieć-Kononowicz K
    Inflamm Res; 2017 Jan; 66(1):79-95. PubMed ID: 27766379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H
    Grosicki M; Adami M; Micheloni C; Głuch-Lutwin M; Siwek A; Latacz G; Łażewska D; Więcek M; Reiner-Link D; Stark H; Chlopicki S; Kieć-Kononowicz K
    Eur J Pharmacol; 2021 Jan; 890():173611. PubMed ID: 33017589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl derivatives of 1,3,5-triazine as histamine H
    Łażewska D; Mogilski S; Hagenow S; Kuder K; Głuch-Lutwin M; Siwek A; Więcek M; Kaleta M; Seibel U; Buschauer A; Filipek B; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2019 Apr; 27(7):1254-1262. PubMed ID: 30792106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisubstituted 1,3,5-Triazines as Histamine H
    Olejarz-Maciej A; Mogilski S; Karcz T; Werner T; Kamińska K; Kupczyk J; Honkisz-Orzechowska E; Latacz G; Stark H; Kieć-Kononowicz K; Łażewska D
    Molecules; 2023 May; 28(10):. PubMed ID: 37241939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
    Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
    Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
    Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
    Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
    Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
    Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
    J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Synthesis of 1,3,5-triazine Derivatives and JNJ7777120 Analogues with Histamine H4 Receptor Affinity and Their Interaction with PTEN Promoter.
    Latacz G; Kechagioglou P; Papi R; Łażewska D; Więcek M; Kamińska K; Wencel P; Karcz T; Schwed JS; Stark H; Kyriakidis DA; Kieć-Kononowicz K
    Chem Biol Drug Des; 2016 Aug; 88(2):254-63. PubMed ID: 26931395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands.
    Kobayashi T; Watanabe M; Yoshida A; Yamada S; Ito M; Abe H; Ito Y; Arisawa M; Shuto S
    Bioorg Med Chem; 2010 Feb; 18(3):1076-82. PubMed ID: 20045649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.